De-medicalization of birth by reducing the use of oxytocin for augmentation among first-time mothers – a prospective intervention study

Table 3 OR for operative vaginal delivery in women augmented with oxytocin, compared to women not augmented, before and after the intervention. Women with caesarean sections are excluded

		OVD	SVD	OR/CI Unadjusted	p-value Unadjusted	OR/CI Adjusted ^b	p-value Adjusted
Before the intervention N = 402	Oxytocin^a,bn = 241	90 (34%)	151	3.1(1.9 -5.1)	< 0.001	2.1 (1.1-4.0)	0.026
Before the intervention N = 402	No oxytocin n = 161	26 (10%)	135		1 (ref)
After the intervention N = 596	Oxytocin^a,bn = 288	107 (32%)	181	4.7 (2.9 -6.8)	< 0.001	2.7 (1.6-4.5)	< 0.001
After the intervention N = 596	No oxytocin n = 308	36 (11%)	272		1 (ref)

CS: n = 29 before and n = 68 after the intervention are excluded
^a Oxytocin for more than 20 min
^b Adjusted for labor duration, birth weight and epidural
Response variables: OVD operative vaginal delivery, SVD spontaneous vaginal delivery

ISSN: 1471-2393